1. Home
  2. KBONU vs YDESW Comparison

KBONU vs YDESW Comparison

Compare KBONU & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KBONU

Karbon Capital Partners Corp. Units

N/A

Current Price

$10.25

Market Cap

0.0

Sector

Finance

ML Signal

N/A

YDESW

YD Bio Limited Warrants

N/A

Current Price

$0.28

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KBONU
YDESW
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
15
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
KBONU
YDESW
Price
$10.25
$0.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.2K
4.9K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.01
$0.25
52 Week High
$11.10
$2.85

Technical Indicators

Market Signals
Indicator
KBONU
YDESW
Relative Strength Index (RSI) 62.25 37.57
Support Level $10.16 N/A
Resistance Level $10.50 $0.58
Average True Range (ATR) 0.02 0.02
MACD 0.00 -0.00
Stochastic Oscillator 54.55 24.85

Price Performance

Historical Comparison
KBONU
YDESW

About KBONU Karbon Capital Partners Corp. Units

Karbon Capital Partners Corp is a blank check company.

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Share on Social Networks: